What is the Origin of L-Theanine Protocol?

L-Theanine was first isolated from green tea in Japan in 1949, and its clinical use is based on decades of neuroscience research into its unique psychoactive and anxiolytic properties. The term "protocol" signifies a deliberate, dosage-controlled, and evidence-based use of this compound to achieve specific, predictable neurological outcomes in a clinical setting.

What is the Mechanism of L-Theanine Protocol?

L-Theanine's primary mechanism involves crossing the blood-brain barrier to directly influence inhibitory neurotransmitter systems. It promotes the generation of alpha brain waves, which are electroencephalographic markers associated with a state of calm alertness, while simultaneously increasing the synthesis of the inhibitory neurotransmitters GABA and glycine. Furthermore, L-Theanine may also modulate the release and reuptake of serotonin and dopamine, contributing to its broad anxiolytic and neuroprotective effects.

L-Theanine Protocol ∞ Area

L-Theanine Protocol

Meaning

L-Theanine Protocol refers to the structured, clinical application of the non-protein amino acid L-Theanine, a bioactive compound primarily sourced from Camellia sinensis (tea leaves), to therapeutically modulate brain activity. The protocol is utilized to promote a state of relaxed, focused attention, support stress management, and improve the quality of sleep without inducing frank sedation. It is a valuable tool in hormonal health for its ability to temper the physiological and neurochemical components of the chronic stress response.